I have created this chart to visually represent the universal role Bisantrene plays in cardioprotection against common cardiotoxic chemotherapies. A 1 uM dose of Bisantrene significantly improves HCM viability (p < 0.001). The real value for this opportunity is that while providing cardioprotection, Bisantrene improves cancer cell killing in combination with these chemotherapies. There are already 2 clinical trials where Bisantrene is used in combination with moderately cardiotoxic chemotherapies not listed in the figure below that achieved combined ORR of 46% and 40% with no clinically relevant signs of cardiotoxicity.
A drug with a universal cardioprotection mechanism combined with a universal cytotoxicity mechanism has not existed until now.
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
Cardioprotection thread, page-518
-
- There are more pages in this discussion • 388 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.68 |
Change
-0.020(1.18%) |
Mkt cap ! $286.3M |
Open | High | Low | Value | Volume |
$1.69 | $1.69 | $1.65 | $91.80K | 55.06K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 337 | $1.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.70 | 4302 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7000 | 1.655 |
6 | 49453 | 1.650 |
1 | 1041 | 1.645 |
2 | 7200 | 1.640 |
1 | 532 | 1.630 |
Price($) | Vol. | No. |
---|---|---|
1.675 | 942 | 1 |
1.685 | 8688 | 2 |
1.690 | 3000 | 1 |
1.700 | 5499 | 5 |
1.720 | 1000 | 1 |
Last trade - 15.22pm 18/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |